Advertisement

Ophthalmology

Andrew Holzman, MD, board certified ophthalmologist, has had his McLean, Va., practice site sanctioned by the FDA as a test site for the cross-linking treatment of kerataconus.

Advertisement

Mobius Therapeutics, ophthalmic surgery solutions company based in St. Louis, has announced that the Center for Medicare & Medicaid Services has given the company Outpatient Prospective Payment System Payment Indicator K2 for the reimbursement of Mitosol.

MacuLogix, a company focused on the detection and following of age-related macular degeneration, has announced that the company has received $3.6 million in Series A funding for its AdaptDx.

Advertisement